Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ABUS - Arbutus Biopharma Corporation
30.6 M
LAST VALUE
-52.74%
2 YEAR CAGR
-11.23%
5 YEAR CAGR
-0.65%
10 YEAR CAGR